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Electrically contractile polymers augment right ventricular output in the heart 
Abstract 
Research into the development of artificial heart muscle has been limited to assembly of stem cell-
derived cardiomyocytes seeded around a matrix, while nonbiological approaches to tissue engineering 
have rarely been explored. The aim of the study was to apply electrically contractile polymer-based 
actuators as cardiomyoplasty for positive inotropic support of the right ventricle. Complex trilayer 
polypyrrole (PPy) bending polymers for high-speed applications were generated. Bending motion 
occurred directly as a result of electrochemically driven charging and discharging of the PPy layers. In a 
rat model (n=5), strips of polymers (3x20mm) were attached and wrapped around the right ventricle (RV). 
RV pressure was continuously monitored invasively by direct RV cannulation. Electrical activation 
occurred simultaneously with either diastole (in order to evaluate the polymer's stand-alone contraction 
capacity; group 1) or systole (group 2). In group 1, the pressure generation capacity of the polymers was 
measured by determining the area under the pressure curve (area under curve, AUC). In group 2, the RV 
pressure AUC was measured in complexes directly preceding those with polymer contraction and 
compared to RV pressure complexes with simultaneous polymer contraction. In group 1, the AUC 
generated by polymer contraction was 2768 +/- 875U. In group 2, concomitant polymer contraction 
significantly increased AUC compared with complexes without polymer support (5987 +/- 1334U vs. 4318 
+/- 691U, P≤0.01). Electrically contractile polymers are able to significantly augment right ventricular 
contraction. This approach may open new perspectives for myocardial tissue engineering, possibly in 
combination with fetal or embryonic stem cell-derived cardiomyocytes. 
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Abstract: Research into the development of artificial 
heart muscle has been limited to assembly of stem cell- 
derived cardiomyocytes seeded around a matrix, while 
nonbiological approaches to tissue engineering have rarely 
been explored. The aim of the study was to apply 
electrically contractile polymer-based actuators as cardi- 
omyoplasty for positive inotropic support of the right 
ventricle. Complex trilayer polypyrrole (PPy) bending 
polymers for high-speed applications were generated. 
Bending motion occurred directly as a result of electro- 
chemically driven charging and discharging of the PPy 
layers. In a rat model (n = 5), strips of polymers (3 ×    20 
mm) were attached and wrapped around the right ven- 
tricle (RV). RV pressure was continuously monitored 
invasively by direct RV cannulation. Electrical activation 
occurred simultaneously with either diastole (in order to 
evaluate the polymer’s stand-alone contraction capacity; 
group 1) or systole (group 2). In group 1, the pressure  
generation capacity of the polymers was measured by 
determining the area under the pressure curve (area under 
curve, AUC). In group 2, the RV pressure AUC was mea- 
sured in complexes directly preceding those with polymer 
contraction and compared to RV pressure complexes with 
simultaneous polymer contraction. In group 1, the AUC 






group 2, concomitant polymer contraction significantly 
increased AUC compared with complexes without 
polymer support  (5987 ± 1334 U  vs.  4318 ± 691 U,  P ≤ 
0.01). Electrically contractile polymers are able to signi- 
ficantly augment right ventricular contraction. This 
approach may open new perspectives for myocardial tissue 
engineering, possibly in combination with fetal or embry- 
onic stem cell-derived cardiomyocytes. Key Words: 
Right ventricle—Tissue engineering—Animal model— 
Heart failure approaches—Contractile polymers. 
 
While heart transplantation, which creates a need 
for lifelong immunosuppression, remains the gold 
standard for the therapy of advanced and end-stage 
heart failure (1), research into regenerative therapy 
for partial or complete replacement of diseased myo- 
cardium by means of tissue engineering has led to 
remarkable results. Engineered heart tissue consist- 
ing of a collagen matrix and neonatal cardiomyocytes 
has been transplanted into small animals, resulting 
in improvement of ventricular function, and whole- 
heart tissue engineering has been performed by 
decellularization and reseeding of cells, essentially 
restoring myocardial function (2,3). Myocardial 
patches have also been created from embryonic stem 
cells (4). However, several challenges need to be 
overcome. Finding the optimal cell source remains a 
challenge. Fetal and neonatal cardiomyocytes are not 
available in large numbers, and embryonic stem cell- 
derived or induced pluripotent stem cell-derived cells 
may cause teratoma (5). Additionally, nutrition of 
the constructs is dependent on diffusion, as no effec- 
tive vascularization concept is available. 
In analogy to cardiomyocytes, the application of 
polymers that contract upon low-voltage electrical 
stimulation could provide an additional tool for sys- 
tolic augmentation of ventricular function. We have 
previously developed and characterized complex 
actuators consisting of trilayer polypyrrole (PPy) 
polymers that have the capacity for contraction and 
bending upon electrical stimulation at a low voltage of 
0.5–1.0 V (6). 
Due to the still limited force that can be generated, 
the low-pressure system of the circulation is the most 
likely target of myocardial tissue engineering 
approaches. The right ventricle, as an important part 
of the low-pressure system of the circulation, repre- 
sents a suitable initial target for the study of myocar- 







FIG. 1. Schematic structure of PPy 
actuator and principle of operation. 
Shrinkage occurs at negative voltages 
due to the expulsion of ions and solvent 
as the PPy discharges. A bending motion 
is then produced when a potential differ- 




The aim of the present study was to apply electri- 
cally contractile polymer-based actuators as cardio- 
myoplasty for positive inotropic support of the right 
ventricle. 
 
MATERIALS AND METHODS 
 
Synthesis of contracting actuators 
The contractile polymers were multilayer struc- 
tures that have been described previously (6). Con- 
struction began by application of a thin, porous gold 
layer to both sides of a sheet of filter membrane 
material using sputter coating. The membrane con- 
sisted of polyvinylidene fluoride (PVDF) and was 
supplied as 110-μm-thick sheets with an average pore 
size of 0.45 μm. The gold coating was approximately 
20–30 nm thick. A PPy coat was then applied on top 
of the gold layers to a thickness of 30 μm on both 
sides of the membrane. PPy was deposited using an 
electrochemical polymerization process using a con- 
stant current density of 0.1 mA/cm2 at −31°C for  10 
h. The reaction solution contained 0.1 M lithium 
trifluoromethanesulfonimide (LiTFSI) dissolved in 
propylene carbonate containing 1% (wt/wt) water. 
Before use, the bending actuators were thoroughly 
washed to remove any unreacted monomer and then 
soaked in propylene carbonate containing 0.1 M 
LiTFSI. This solution was absorbed into the pores of 
the PVDF membrane and acted as the electrolyte 
needed for bending actuation, as described below. 
Strips of multilayer bending actuators were cut from 
larger sheets to approximately 30 × 2 mm. Electrical 
connections were made to both PPy layers at one end 
of each strip using platinum wire, and the entire  
assembly was sealed using a solvent-based acrylic 
polymer solution. 
 
Mechanism of action 
The bending motion occurs directly as a result of the 
electrochemically driven charging and discharging of 
the PPy layers. Charging the PPy by applying a posi- 
tive voltage causes it to expand as it absorbs ions and 
solvent from the liquid electrolyte contained within 
the porous PVDF membrane. Shrinkage occurs at 
negative voltages due to the expulsion of ions and 
solvent as the PPy discharges. A bending motion is 
then produced when a potential difference is applied 
across the multilayer structure. A simple 1.5-V battery 
was used directly to power the actuator, with a polar- 
ity switch used to reverse the direction of bending. 
The structure of the multilayer actuators and principle 
of bending motion are illustrated in Fig. 1. 
 
Reagents and materials 
Pyrrole monomer was purchased from Merck KGaA 
(Darmstadt, Germany) and purified by distil- lation 
before use. PVDF membranes of 0.45 μm pore size 
(Millipore, Billerica, MA, USA) were used as backing 
materials. LiTFSI was bought from 3M (St. Paul, MN, 
USA), and propylene carbonate was from Sigma-
Aldrich (Castle Hill, Australia). 
 
Anesthesia and surgical technique 
During all experiments, the Principles of Labora- 
tory Animal Care (NIH publication no. 86-23, revised 
1985), as well as federal guidelines for the use of 
human tissue and the Animal Welfare Law of the 
state of Baden Württemberg, Germany, were fol- 
lowed. In a rat model (n = 5), anesthesia was per- 
formed by intraperitoneal injection of a combination 
of ketamine (100 mg/kg body weight) and xylazine 
(3 mg/kg body weight), and the animals were put on 
a respirator (Small Animal Pressure Controlled 
Ventilator KTR-5 Dual Version, Hugo Sachs 
Elektronik–Harvard Apparatus GmbH, March- 
Hugstetten, Germany). The animals were hepari- 
nized using 400 IU/kg of heparin. 
Via median sternotomy, strips of polymer were 
wrapped around and attached to the right ventricle. 
Strips   of   polymer   were   cut   to   the   size   of      3 
mm × 20 mm and wrapped semicircumferentially 
around the heart so that the right ventricle was covered. 
Attachment was performed using Bioglue Surgical 
Adhesive (Cryolife, Freiburg, Germany). Bioglue was 
identified as the best adhesive material after suturing 
with polypropylene, fibrin glue, and French glue did 
not produce reliable  results.  The  free end of the 








FIG. 2. Schematic of the setup of the electrically contractile 
polymer around the right ventricle. 
 
electrodes that were attached to an electronic switch. 




Right ventricular (RV) pressure was continuously 
measured invasively by direct RV cannulation with a 
24G cannula. In analogy to the pulse contour cardiac 
output system (PiCCO; Pulsion Medical Systems 
AG, Munich, Germany), which calculates the stroke 
volume variation by continuous analysis of the arte- 
rial pulse contour (7), the right ventricular area under 
the pressure–time curve was measured in arbitrary 
units (U) as a correlate to stroke volume. The 
artifact-free complexes were chosen for analysis. This 
RV-pressure area under the curve (AUC) was 
measured in complexes directly preceding those 
with polymer contraction and compared with RV- 
pressure complexes with polymer contraction during 
systole or diastole. Monitoring was performed using 
an APT300 blood pressure transducer, Plugsys Mini 
Case Type 609 Amplifier, and HSE-BDAS W soft- 
ware (all Hugo Sachs Elektronik–Harvard Appara- 
tus GmbH) and recorded on a computer (Toshiba 
Satellite Pro L300, Neuss, Germany). 
 
Polymer activation 
Electrical activation (0.5 V) occurred simultane- 
ously with diastole (immediately after the end of sys- 
tolic contraction) in order to evaluate the polymer’s 
stand-alone contraction capacity (group 1) or at the 
beginning of systolic contraction in order to evaluate 
systolic augmentation capacity for the right ventricle 




The statistical analysis was performed with SPSS 
version 20 (SPSS, Inc., Chicago, IL, USA). The rela- 
tive change compared with the AUC before polymer 
contraction was expressed as a percentage. Variables 
were expressed as mean ± standard deviation. The 
AUCs with and without polymer contraction were 
compared using the paired t-test after testing for 
normality of distribution and application of the 
Wilcoxon signed rank test. The relationships 
between the variables were further characterized 
using Pearson’s correlation analysis and regression 
analysis. The results were considered to be significant 




Successful establishment of animal model 
Seventy-two animals were required for success-  ful 
implementation of the animal model. Creation of a 
polymer–myocardium interface with 1:1 force 
transduction from polymer to the right ventricle was 
the greatest challenge in this model. After several 
attempts using fibrin glue (Baxter GmbH, Unter- 
schleissheim, Germany), gelatin–resorcinol–formalin 
glue (Cardial, Technopole, Sainte-Etienne, France) 
and polypropylene sutures, Bioglue Surgical Adhe- 
sive (Cryolife) turned out to be the only means to 
achieve high mechanical stability in this model. 
 
Stand-alone pressure generation capacity of 
the polymer 
In group 1, where polymer contraction was acti- 
vated during diastole, the AUC generated by  
polymer contraction was 2768 ± 875 U (Fig. 4C). 
 
Improvement of right ventricular function by 
polymer contraction 
Concomitant polymer contraction significantly 
increased AUC compared with complexes without 
polymer support. Figures 4–6 show the final results. 
Figure 5 shows that an increase in the AUC was 
achieved following polymer contraction in all 63 
measurements. The relative increase in the AUC 
before polymer contraction (4318.33 ± 691.34 U) 
compared with the AUC after polymer contrac- tion 


















FIG. 3. Successful establishment of 
animal model. Animals were thora- 
cotomized, and invasive right ventricular 
pressure was recorded. Arrows show 
















measurement series were found to be statistically 
different using the parametric paired t-test (P < 0.01) 
and the nonparametric Wilcoxon signed-rank test (P 
< 0.01). We found a significant correlation between 
both series using the Pearson coefficient (P < 0.01). 
The relative change was compared with the AUC 
before the intervention in Fig. 6. The regression 
analysis found a quadratic relationship (P < 0.01) 
between these variables, suggesting that the 
observed relative changes in AUC were greatest in 
hearts with moderate preintervention contractility. 
 
DISCUSSION 
A rat model involving stable attachment of electri- 
cally contractile polymers around the right ventricle 
and invasive recording of right ventricular pressure 
and stroke volume was successfully established. Con- 
tinuous invasive measurement of right ventricular 
pressure without and with electrical activation of 
contractile polymers revealed a significant increase in 
AUC and thereby right ventricular stroke volume 
upon electrical activation and contraction of the 
polymer. In analogy to the left ventricle in other 
 
studies, the greatest benefit was observed in animals 
in which right ventricular stroke volume was moder- 
ate due to loss of blood, mechanical manipulation of 
the right ventricle, or the effect of the glue that was 
used for the attachment of the polymer during the 
experiment. 
Wrapping of engineered structures around  the  heart 
for support of myocardial function has been performed 
with noncontractile devices such as Acorn 
Cardiovascular’s CorCap polyester mesh (CSD; Acorn 
Cardiovascular, Inc., St. Paul, MN, USA), resulting in 
reduced stress on myocardial fibers (8). The use of 
contractile elements around the heart should have a 
more synergistic effect on myocardial function. As 
most tissue engineering approaches for the 
augmentation of myocardial function will most likely 
be performed on the right ventricle due to the limited 
power these constructs can generate, a con- ceivable 
clinical application would be in the Fontan circulation, 
as moderate increase in right atrial pres- sure can 
significantly improve pulmonary artery flow and lung 
perfusion. Voss et al. were able to achieve this goal by 
dynamic cardiomyoplasty using skeletal muscle in a 















































FIG. 4. Concomitant polymer contraction significantly increased 
AUC compared with complexes without polymer support. Repre- 
sentative invasive measurement results of right ventricular pres- 
sure during systole show augmentation of RV pressure during 
systole by polymer contraction (red arrows, A and B) and stand- 
alone capacity for pressure generation of the polymer by contrac- 
tion during diastole (red arrow, C). 
 
FIG. 5. Boxplot showing a direct comparison of medians and data 
distribution before and after polymer contraction in group 2. 
Concomitant polymer contraction significantly increased AUC 
compared with complexes without polymer support. 
 
 
We made compromises in order to show proof   of 
concept of increase of RV output by contractile 
polymers. However, several limitations of our study 
design need to be addressed. 
The maximum contraction rate that can be 
achieved by the polymers is 60/min. Therefore RV 
augmentation could not be performed for every 
cardiac cycle due to the high heart rate in this animal 
model. We avoided administration of negative 
chronotropic drugs as they may also have a negative 
inotropic effect. 
Additionally, titration of adenosine and short- 
effect beta-blockers such as esmolol turned out to be 
 
of the polymers shows a similar gross structure as 
present in the myocardium itself, showing contractile 
fibers with large spaces between them, possibly 
allowing for additional seeding of cardiomyocytes 
onto the polymer with the intention for synergistic 
generation of force in future studies (Supporting 
Information Fig. S1). Another challenge will be the 
elimination of fatigue and increase of durability, 
which is at this point limited to several hours but is 
already increasing with new-generation polymers 
(articles in preparation). Moreover, although proof 
of concept with regard to augmentation of cardiac 
output was achieved, it remains to be demonstrated 
that contractile polymers are as effective in animal 
models with RV failure as in our experimental 
setting, where, as a first step, animals with healthy 
right ventricles were chosen. 
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FIG. 6. Scatterplot comparing the AUC without polymer contrac- 
tion with the relative increase in AUC following polymer contrac- 
tion in group 2. The quadratic distribution (P < 0.01) suggests that 
rat hearts with moderate preinterventional AUC received the 
greatest benefit from polymer contraction. 
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unreliable with regard to the duration of bradycardia 
and hemodynamic instability. However, with techni- 
cal progress, higher contraction rates, and larger sizes 
of the polymers, large-animal experiments will be 
feasible. In the future, we plan to document RV 
output in such an experiment, using continuous 
pressure-volume loops in order to bolster our results. 
 
CONCLUSION 
Electrically contractile polymers are able to signifi- 
cantly augment right ventricular contraction. Our 
approach may open new perspectives for myocardial 
tissue engineering, possibly in combination with 
cardiomyocytes. 
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Additional Supporting Information may be found in 
the online version of this article at the publisher’s 
web-site: 
Fig. S1. Tenfold magnification of the contracting 
polymer reveals spaces between the fibers, possibly 
allowing for seeding of cardiomyocytes onto the 
polymer, with the potential for synergistic effects. 
